| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020 | 1642 | 2020 |
| FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis M Suker, BR Beumer, E Sadot, L Marthey, JE Faris, EA Mellon, ... The Lancet Oncology 17 (6), 801-810, 2016 | 926 | 2016 |
| Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial E Versteijne, M Suker, K Groothuis, JM Akkermans-Vogelaar, ... Journal of clinical oncology 38 (16), 1763-1773, 2020 | 877 | 2020 |
| Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial J Van Hilst, T de Rooij, K Bosscha, DJ Brinkman, S van Dieren, ... The lancet Gastroenterology & hepatology 4 (3), 199-207, 2019 | 546 | 2019 |
| Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer E Versteijne, JA Vogel, MG Besselink, ORC Busch, JW Wilmink, ... Journal of British Surgery 105 (8), 946-958, 2018 | 505 | 2018 |
| Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial T de Rooij, J van Hilst, H van Santvoort, D Boerma, P van den Boezem, ... Annals of surgery 269 (1), 2-9, 2019 | 492 | 2019 |
| Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the Dutch randomized PREOPANC trial E Versteijne, JL van Dam, M Suker, QP Janssen, K Groothuis, ... Journal of Clinical Oncology 40 (11), 1220-1230, 2022 | 418 | 2022 |
| Alternative fistula risk score for pancreatoduodenectomy (a-FRS): design and international external validation TH Mungroop, LB Van Rijssen, D Van Klaveren, FJ Smits, ... Annals of surgery 269 (5), 937-943, 2019 | 339 | 2019 |
| Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis QP Janssen, S Buettner, M Suker, BR Beumer, P Addeo, P Bachellier, ... JNCI: Journal of the National Cancer Institute 111 (8), 782-794, 2019 | 308 | 2019 |
| Surgery for cholangiocarcinoma U Cillo, C Fondevila, M Donadon, E Gringeri, F Mocchegiani, HJ Schlitt, ... Liver international 39, 143-155, 2019 | 296 | 2019 |
| Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): a pan-European propensity score matched study J Van Hilst, T De Rooij, S Klompmaker, M Rawashdeh, F Aleotti, ... Annals of surgery 269 (1), 10-17, 2019 | 264 | 2019 |
| International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer S Van Roessel, GG Kasumova, J Verheij, RM Najarian, L Maggino, ... JAMA surgery 153 (12), e183617-e183617, 2018 | 263 | 2018 |
| Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons P Sánchez-Velázquez, X Muller, G Malleo, JS Park, HK Hwang, N Napoli, ... Annals of surgery 270 (2), 211-218, 2019 | 258 | 2019 |
| The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a … MH Aziz, K Sideras, NA Aziz, K Mauff, R Haen, D Roos, L Saida, M Suker, ... Annals of surgery 270 (1), 139-146, 2019 | 246 | 2019 |
| Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant JK Wiggers, BG Koerkamp, KP Cieslak, A Doussot, D van Klaveren, ... Journal of the American College of Surgeons 223 (2), 321-331. e1, 2016 | 215 | 2016 |
| Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure? JM Creasy, E Sadot, BG Koerkamp, JF Chou, M Gonen, NE Kemeny, ... Surgery 163 (6), 1238-1244, 2018 | 207 | 2018 |
| Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? E Sadot, BG Koerkamp, JN Leal, J Shia, M Gonen, PJ Allen, RP DeMatteo, ... Annals of surgery 262 (3), 476-485, 2015 | 207 | 2015 |
| Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent XF Zhang, EW Beal, F Bagante, J Chakedis, M Weiss, I Popescu, ... Journal of British Surgery 105 (7), 848-856, 2018 | 200 | 2018 |
| Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection BG Koerkamp, JK Wiggers, PJ Allen, MG Besselink, LH Blumgart, ... Journal of the American College of Surgeons 221 (6), 1041-1049, 2015 | 197 | 2015 |
| Textbook outcome: nationwide analysis of a novel quality measure in pancreatic surgery S van Roessel, TM Mackay, S van Dieren, GP van der Schelling, ... Annals of surgery 271 (1), 155-162, 2020 | 186 | 2020 |
Marc G BesselinkProfessor of Pancreatic and Hepatobiliary (HPB) surgery, Amsterdam UMC, University of Amsterdam在 amsterdamUMC.nl 的电子邮件经过验证
